CIK 0001649904
- Large accelerated filer
RHYTHM PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- RYTM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 462159271
- Phone
- +1 857-264-4280
- Business address
- 222 BERKELEY STREET, 12TH FLOOR, BOSTON, MA, 02116
- Former names
- RHYTHM METABOLIC, INC.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $11,753,355
- in 2 filings, $11.8M under 10b5-1 plans
Net −$11,753,355. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-09 | Lee Jennifer Kayden EVP, Head of North America | Option exercise · Restricted Stock Units 10b5-1 | −3,437 | 3,437 | ||
| 2025-02-09 | Lee Jennifer Kayden EVP, Head of North America | Option exercise · Stock Option (Right to Buy) 10b5-1 | −4,189 | 21,601 | ||
| 2025-02-09 | Cramer Pamela J. Chief Human Resources Officer | Option exercise 10b5-1 | +2,344 | 17,592 | ||
| 2025-02-09 | Cramer Pamela J. Chief Human Resources Officer | Option exercise · Restricted Stock Units 10b5-1 | −2,344 | 2,343 | ||
| 2025-02-09 | Smith Hunter C Chief Financial Officer | Option exercise 10b5-1 | +4,062 | 105,248 | ||
| 2025-02-09 | Smith Hunter C Chief Financial Officer | Option exercise · Restricted Stock Units 10b5-1 | −4,062 | 4,062 | ||
| 2025-02-05 | Lee Jennifer Kayden EVP, Head of North America | Sale 10b5-1 | −1,733 | $60.08 | $104K | 2,305 |
| 2025-02-05 | Lee Jennifer Kayden EVP, Head of North America | Sale 10b5-1 | −1,133 | $61.01 | $69K | 1,172 |
| 2025-02-05 | Lee Jennifer Kayden EVP, Head of North America | Sale 10b5-1 | −200 | $61.95 | $12K | 972 |
| 2025-02-04 | Smith Hunter C Chief Financial Officer | Sale | −1,678 | $59.43 | $100K | 101,186 |
| 2025-02-04 | Shulman Joseph Chief Technical Officer | Sale | −1,281 | $59.43 | $76K | 2,657 |
| 2025-02-04 | Meeker David P President and CEO | Sale | −4,278 | $59.43 | $254K | 189,927 |
| 2025-02-04 | Lee Jennifer Kayden EVP, Head of North America | Sale | −1,447 | $59.43 | $86K | 4,038 |
| 2025-02-04 | Cramer Pamela J. Chief Human Resources Officer | Sale | −902 | $59.43 | $54K | 15,248 |
| 2025-02-01 | Smith Hunter C Chief Financial Officer | Option exercise | +4,925 | 102,864 | ||
| 2025-02-01 | Smith Hunter C Chief Financial Officer | Option exercise · Restricted Stock Units | −4,925 | 9,850 | ||
| 2025-02-01 | Shulman Joseph Chief Technical Officer | Option exercise | +3,938 | 3,938 | ||
| 2025-02-01 | Shulman Joseph Chief Technical Officer | Option exercise · Restricted Stock Units | −3,938 | 7,874 | ||
| 2025-02-01 | Meeker David P President and CEO | Option exercise | +14,125 | 194,205 | ||
| 2025-02-01 | Meeker David P President and CEO | Option exercise · Restricted Stock Units | −14,125 | 28,250 |
Page 20 of 36 · 701 trades